Trials / Completed
CompletedNCT01338922
Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 Diabetes Mellitus (DM)
Psychosocial Issues in Insulin Pump Therapy in Children With Type 1 DM - a Randomised Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 211 (actual)
- Sponsor
- University Hospital Schleswig-Holstein · Academic / Other
- Sex
- All
- Age
- 6 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
The effect of change in diabetes treatment from multiple daily insulin injection therapy to continuous subcutaneous insulin infusion on psychosocial outcome measures (quality of life, diabetes burden, parents stress level, fear, family conflicts) in families with children and adolescents with diabetes mellitus type 1 have been analysed. Additionally the effect on metabolic parameters (HbA1c, severe Hypoglycemia, Ketoacidosis) have been analysed.
Detailed description
Children and adolescents currently treated with MDI and with an indication for CSII were randomized 1:1 to either starting with CSII as soon as possible or to continuing MDI while waiting six months for transmission to CSII, stratified by center. The primary outcomes were patient-reported diabetes-specific health-related quality of life , and diabetes burden of the main caregiver. We also investigated the impact of CSII on main caregiver stress, psychological well-being, fear of hypoglycemia, main caregiver's and adolescent's treatment satisfaction, family conflict, and HbA1c.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Continuous subcutaneous insulin infusion therapy | Insulin is given continuously using an insulin pump. Devices are allowed having marketing approval. Insulins are permitted with marketing approval. |
| DEVICE | Multiple daily injection therapy | Multiple daily injection therapy with different devices and insulin types. Devices and insulin types have to have marketing approval. |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2015-07-01
- Completion
- 2016-08-01
- First posted
- 2011-04-20
- Last updated
- 2018-02-05
Locations
24 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT01338922. Inclusion in this directory is not an endorsement.